Dr. Korczowska received her Master of Pharmacy degree in 2001 from the Poznan University of Medical Sciences. She has been working in hospital pharmacy for more than 20 years, and has a special interest in oncology. In 2009 she qualified as a specialist in hospital pharmacy and in 2019 she completed her doctoral thesis at the Poznan University of Medical Sciences evaluating environmental contamination with antineoplastic drugs in Polish hospitals.

Dr. Korczowska is an active member of Polish Pharmaceutical Society, Polish Association of Oncology Pharmacists and European Society of Oncology Pharmacy (ESOP). Since 2008, she has been a member of the Masterclass Faculty at ESOP. She is also a member of the Education Committee supporting European Specialization in Oncology Pharmacy provided by the Academy of the European Society of Oncology Pharmacy (EUSOP). Between 2019 – 2022 Dr. Korczowska was Vice President, Internal at ESOP. Currently, she is Coordinator of the ESOP Working Group on safe working and occupational exposure (MASHA). Its objective is to make recommendations which lead to improvements in the safe handling of these drugs.

Dr. Korczowska has taken leadership roles in the safe handling of antineoplastic drugs and in the running of clinical trials in a hospital setting. Between 2021 – 2023, she worked at the University Clinical Trial Support Centre in Poznan as the Clinical Trials Coordinator. She was also a lead investigator in the first study conducted in Poland assessing cytotoxic contamination in Polish hospitals.

Dr. Korczowska is an author of several articles and scientific abstracts (one EAHP poster nomination and one EAHP 3rd Prize award), and the co-author of the Polish Standards in Oncology Pharmacy (3rd edition). She delivers scientific presentations at local, national and international symposia.